Leerink Partners LLC (Leerink) is a U.S.-based investment bank and institutional brokerage focused on the healthcare and life sciences sectors, including biopharma, medical technology, diagnostics, and healthcare services. The firm provides mergers and acquisitions advisory, equity and debt capital markets execution, sales and trading, and equity research for corporate and investor clients.
Originating in Boston and long known for its sector specialization, the franchise previously operated as SVB Leerink under SVB Financial Group before returning to independence and rebranding as Leerink Partners in 2023. While not a chemical producer, its research and advisory work can intersect with areas relevant to the chemical industry, such as pharmaceutical ingredients, specialty materials for medical devices, and life-science supply chains.
Official website: leerink.com
